Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
Jing Wang(Naval Medical Research Command), Boyang Jason Wu(Washington State University Spokane), Baron Bechtold(Washington State University Spokane), Tianjie Pu(Washington State University Spokane), Eva Corey(University of Washington), Jingrui Chen(Washington State University Spokane), A Zeng(University of Washington), Varsha Karthikeyan(Oregon State University), Tyler Bland(University of Idaho), Tzu‐Ping Lin(National Cheng Kung University), Martin Puhr(Innsbruck Medical University), Karen Vo(Washington State University Spokane), Jing Wei(Washington State University Spokane), Zoran Čulig(Innsbruck Medical University), Amy P. Chang, Helmut Klocker(Universität Innsbruck)
Cited by 12
Related Papers
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
|Nature Communications|2014|269
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
|Clinical Cancer Research|2018|236